Currently out of the existing stock ratings of Keith Markey, 12 are a BUY (92.31%), 1 are a HOLD (7.69%).

Keith Markey

Work Performance Price Targets & Ratings Chart

Analyst Keith Markey, carries an average stock price target met ratio of 30% that have a potential upside of 37.42% achieved within 98 days. Previously, Keith Markey worked at GUGGENHEIM, EVERCORE, GRIFFIN SECURITIES.

Keith Markey’s has documented 26 price targets and ratings displayed on 3 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on PGEN, Precigen at 06-Jun-2016.

Wall Street Analyst Keith Markey

Analyst best performing recommendations are on XON (PRECIGEN).
The best stock recommendation documented was for XON (PRECIGEN) at 2/23/2015. The price target of $65 was fulfilled within 163 days with a profit of $25.7 (65.39%) receiving and performance score of 4.01.

Average potential price target upside

XON Precigen MNKD MannKind Corp PGEN Precigen

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 04-Oct-2017

$27

$24.28 (892.65%)

6 years 10 months 17 days ago
(13-Nov-2019)

0/3 (0%)

$21.53 (393.60%)

Buy Since 19-Oct-2015

$50

7 years 6 months 29 days ago
(01-Mar-2019)

1/3 (33.33%)

$16.58 (49.61%)

37

Buy Since 10-Nov-2015

$57

$54.28 (1995.59%)

$69

10 years 6 months 29 days ago
(01-Mar-2016)

0/3 (0%)

$23.59 (70.61%)

Hold Since 10-Nov-2015

$28

10 years 7 months ago
(01-Mar-2016)

1/2 (50%)

$1.52 (5.74%)

3

Buy Since 23-Feb-2015

$65

$62.28 (2289.71%)

$65

10 years 8 months 2 days ago
(28-Jan-2016)

2/4 (50%)

$36.28 (126.32%)

146

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?